Y. Chen

2.0k total citations · 1 hit paper
27 papers, 1.4k citations indexed

About

Y. Chen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cognitive Neuroscience. According to data from OpenAlex, Y. Chen has authored 27 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 6 papers in Cognitive Neuroscience. Recurrent topics in Y. Chen's work include Lung Cancer Treatments and Mutations (9 papers), Colorectal Cancer Treatments and Studies (6 papers) and Functional Brain Connectivity Studies (6 papers). Y. Chen is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Colorectal Cancer Treatments and Studies (6 papers) and Functional Brain Connectivity Studies (6 papers). Y. Chen collaborates with scholars based in China, United Kingdom and United States. Y. Chen's co-authors include Shuyun Xu, Peng Li, Li Zhang, Min Zhou, Y. Wang, Li Xie, Fangfang Zhu, Qian Chu, Peipei Zhang and Jianping Zhao and has published in prestigious journals such as Scientific Reports, Neuroscience and Annals of Oncology.

In The Last Decade

Y. Chen

26 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China

2020 988 citations Y. Chen et al. Annals of Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Y. Chen China	12	846	526	195	161	137	27	1.4k
Dong Ji China	21	218 0.3×	479 0.9×	91 0.5×	140 0.9×	91 0.7×	71	1.7k
Yan Ma China	21	219 0.3×	252 0.5×	165 0.8×	136 0.8×	104 0.8×	119	1.6k
Changchuan Jiang United States	18	450 0.5×	116 0.2×	269 1.4×	137 0.9×	72 0.5×	98	1.6k
Wai Keong Wong United Kingdom	15	237 0.3×	187 0.4×	183 0.9×	59 0.4×	103 0.8×	36	1.1k
Beth Sherrill United States	17	350 0.4×	50 0.1×	131 0.7×	35 0.2×	82 0.6×	38	1.2k
Faming Zhao China	9	350 0.4×	1.0k 2.0×	78 0.4×	52 0.3×	70 0.5×	24	1.6k
Massimo Vicentini Italy	17	430 0.5×	214 0.4×	179 0.9×	43 0.3×	69 0.5×	55	1.0k
Suman Kundu United States	18	129 0.2×	87 0.2×	161 0.8×	108 0.7×	54 0.4×	44	1.3k
Marie‐Hélène Lafeuille United States	23	117 0.1×	128 0.2×	411 2.1×	55 0.3×	50 0.4×	148	2.0k
Laura Fabbri Italy	14	241 0.3×	148 0.3×	90 0.5×	22 0.1×	67 0.5×	37	928

Countries citing papers authored by Y. Chen

Since Specialization

Citations

This map shows the geographic impact of Y. Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y. Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y. Chen more than expected).

Fields of papers citing papers by Y. Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y. Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y. Chen. The network helps show where Y. Chen may publish in the future.

Co-authorship network of co-authors of Y. Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Y. Chen. A scholar is included among the top collaborators of Y. Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y. Chen. Y. Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cheng, Ying, Yu-Jung Kim, Alejandro Navarro, et al.. (2024). OA04.03 Ifinatamab Deruxtecan (I-DXd) in Extensive-Stage Small Cell Lung Cancer (ES-SCLC): Interim Analysis of Ideate-lung01. Journal of Thoracic Oncology. 19(10). S15–S16. 14 indexed citations

Zheng, Yanting, Yujie Liu, Xinyu Liang, et al.. (2023). Abnormal dynamic functional connectivity of thalamic subregions in patients with first-episode, drug-naïve major depressive disorder. Frontiers in Psychiatry. 14. 1152332–1152332. 4 indexed citations

Sun, Li, Xiaohui Huang, Jianyun Huang, et al.. (2023). EP12.01-01 The Safety and Efficacy of Aumolertinib in Advanced NSCLC Patients with EGFRm Who were Intolerant to Osimertinib: A Retrospective Clinical Study. Journal of Thoracic Oncology. 18(11). S640–S641.

Zhang, Yalin, Lin Wu, Jianwei Hu, et al.. (2023). 1379P Preliminary results of phase II KUNPENG study of vebreltinib in patients (Pts) with advanced NSCLC harboring c-MET alterations. Annals of Oncology. 34. S791–S791. 7 indexed citations

Zheng, Yanting, Yujie Liu, Xinyu Liang, et al.. (2022). Subregion-specific, modality-dependent and timescale-sensitive hippocampal connectivity alterations in patients with first-episode, drug-naïve major depression disorder. Journal of Affective Disorders. 305. 159–172. 11 indexed citations

Lu, Shaoming, Jian Fang, X. Li, et al.. (2022). 2MO Final OS results and subgroup analysis of savolitinib in patients with MET exon 14 skipping mutations (METex14+) NSCLC. Annals of Oncology. 33. S27–S27. 10 indexed citations

Li, Guoshi, Yujie Liu, Yanting Zheng, et al.. (2021). Multiscale neural modeling of resting-state fMRI reveals executive-limbic malfunction as a core mechanism in major depressive disorder. NeuroImage Clinical. 31. 102758–102758. 18 indexed citations

Zhang, Hanyue, Yujie Liu, Xinyu Liang, et al.. (2021). Abnormal Functional Connectivity of Posterior Cingulate Cortex Correlates With Phonemic Verbal Fluency Deficits in Major Depressive Disorder. Frontiers in Neurology. 12. 724874–724874. 8 indexed citations

Liu, Yujie, Y. Chen, Xinyu Liang, et al.. (2020). Altered Resting-State Functional Connectivity of Multiple Networks and Disrupted Correlation With Executive Function in Major Depressive Disorder. Frontiers in Neurology. 11. 272–272. 43 indexed citations

10.

Li, Guoshi, Yujie Liu, Yanting Zheng, et al.. (2019). Large‐scale dynamic causal modeling of major depressive disorder based on resting‐state functional magnetic resonance imaging. Human Brain Mapping. 41(4). 865–881. 58 indexed citations

11.

Zhou, C., Xiaofan Zhu, Yihua Sun, et al.. (2018). OA10.07 Resistance Mechanisms of Osimertinib in Chinese Non-Small Cell Lung Cancer patients: Analysis from AURA17 Trial. Journal of Thoracic Oncology. 13(10). S345–S345. 6 indexed citations

12.

Zhao, Kai, Li Wu, Y. Chen, et al.. (2018). Long-term safety, health and mental status in men with vasectomy. Scientific Reports. 8(1). 15703–15703. 4 indexed citations

13.

Zhou, Caicun, Ying Cheng, Y. Chen, et al.. (2018). AURA17 study of osimertinib in Asia-Pacific patients (pts) with EGFR T790M-positive advanced non-small cell lung cancer (NSCLC): Updated phase II results including overall survival (OS). Annals of Oncology. 29. ix157–ix157. 10 indexed citations

14.

Zhou, Can, Hao Xu, Y. Chen, et al.. (2018). Novel interstitial deletion in Xp22.3 in a typical X-linked recessive family with Kallmann syndrome. Andrologia. 50(4). e12961–e12961. 5 indexed citations

15.

Zhou, C.Z., Ying Cheng, Y. Chen, et al.. (2017). Osimertinib in Asia-Pacific patients (pts) with EGFR T790M-positive advanced NSCLC: Updated Phase II study results including progression-free survival (PFS). Annals of Oncology. 28. v484–v484. 2 indexed citations

16.

Chen, Y., Wang Ju, Kai Zhao, et al.. (2016). The plasma miR-125a, miR-361 and miR-133a are promising novel biomarkers for Late-Onset Hypogonadism. Scientific Reports. 6(1). 23531–23531. 13 indexed citations

17.

Zhao, Kai, et al.. (2015). miR-424/322 is downregulated in the semen of patients with severe DNA damage and may regulate sperm DNA damage. Reproduction Fertility and Development. 28(10). 1598–1607. 25 indexed citations

18.

Huang, Xing, et al.. (2012). Prognostic value of TP/PD-ECGF and thrombocytosis in gastric carcinoma. European Journal of Surgical Oncology. 38(7). 568–573. 22 indexed citations

19.

Wu, Peng, М. А. Ливзан, Guowei Dai, et al.. (2011). The association of metabolic syndrome with reflux esophagitis: a case-control study. Neurogastroenterology & Motility. 23(11). 989–994. 24 indexed citations

20.

Jiao, Lingxia, et al.. (2011). Edaravone alleviates delayed neuronal death and long-dated cognitive dysfunction of hippocampus after transient focal ischemia in Wistar rat brains. Neuroscience. 182. 177–183. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact